These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3114769)

  • 1. Food intake and biogenic amine concentrations in brain regions of chicks following intracerebroventricular injection of six-hydroxydopamine.
    Kuenzel WJ; Snapir N; Rexroad CE
    Pharmacol Biochem Behav; 1987 Jun; 27(2):257-63. PubMed ID: 3114769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of the neurotoxins N-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) and 6-hydroxydopamine on hypothalamic noradrenergic, dopaminergic and 5-hydroxytryptaminergic neurons in the male rat.
    Lookingland KJ; Chapin DS; McKay DW; Moore KE
    Brain Res; 1986 Feb; 365(2):228-34. PubMed ID: 2868785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
    Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
    J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine sulfoconjugation in the rat brain: regulation by monoamine oxidase.
    Buu NT
    J Neurochem; 1985 Aug; 45(2):470-6. PubMed ID: 3925084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depletion of cerebral norepinephrine with 6-hydroxydopamine and GBR-12909 in neonatal rat.
    Teicher MH; Barber NI; Reichheld JH; Baldessarini RJ; Finklestein SP
    Brain Res; 1986 Nov; 395(1):124-8. PubMed ID: 2430678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
    Olds ME; Yuwiler A
    Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The masking of amine accumulation by catecholamine depletion.
    Willis GL; Smith GC; McGrath B
    Brain Res; 1984 Dec; 324(1):43-50. PubMed ID: 6440661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feeding, drinking and body temperature of Leghorn chicks: effects of ICV injections of biogenic amines.
    Denbow DM; Van Krey HP; Lacy MP; Dietrick TJ
    Physiol Behav; 1983 Jul; 31(1):85-90. PubMed ID: 6634981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of insulin binding in the arcuate nucleus of the rat hypothalamus after 6-hydroxydopamine treatment.
    Wilcox BJ; Matsumoto AM; Dorsa DM; Baskin DG
    Brain Res; 1989 Oct; 500(1-2):149-55. PubMed ID: 2514006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues.
    Caramona MM; Soares-da-Silva P
    Br J Pharmacol; 1985 Oct; 86(2):351-6. PubMed ID: 3931730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing effect of taurine in the rat caudate spindle. II. Effect of bilateral 6-hydroxydopamine lesions of the nigro-striatal dopamine system.
    Hashimoto-Kitsukawa S; Okuyama S; Aihara H
    Pharmacol Biochem Behav; 1988 Oct; 31(2):417-23. PubMed ID: 3149745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions.
    Nobrega JN; Coscina DV
    Pharmacol Biochem Behav; 1986 Aug; 25(2):401-9. PubMed ID: 3094039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 6-hydroxydopamine on brain catecholamines and on acute actions of ethanol in LS/Ibg and SS/Ibg mice.
    Erwin VG; Cornell K
    Alcohol Clin Exp Res; 1986 Jun; 10(3):285-9. PubMed ID: 3090901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeding behavior after hypothalamic 6-hydroxydopamine injections.
    Leibowitz SF
    Appetite; 1984 Sep; 5(3):268-71. PubMed ID: 6441518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool.
    Soares-da-Silva P; Davidson R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):253-7. PubMed ID: 3927177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.